Type 2 & other diabetes

Physician‐led medication reviews in polypharmacy patients treated with at least 12 medications in a type 2 diabetes outpatient clinic: A randomised trial

Diabet MedPublished Randomised controlled trial

Primary result · Mean number of medications per patient (change from baseline)Result — go to the resultRate ratio 0.81

Authors' conclusion

Physician-led medication reviews and increased cross-sectoral communication in patients with type 2 diabetes treated with at least 12 medications reduced the number of medications used and improved health-related quality of life. Implementing and further investigating similar interventions as standard care seems reasonable.

Study context

Population
Patients with T2D treated with at least 12 medications, T2D outpatient clinic; median age 72 (IQR 67–75) years
Participants
50 patients
Comparison
Standard care plus physician-led medication review and increased cross-sectoral communication vs standard care
Primary endpoint
Number of medications used
Follow-up
6 months
Methodological detailspragmatic
  • Pragmatic

Primary result

As reported in the abstract

Mean number of medications per patient (change from baseline)

Rate ratio

0.81

Change by group

Intervention

14.3

mean

Standard care

17.2

mean

Further findings

OutcomeDifference (95% CI)
Change in health-related quality of life (EQ5D-5 L index score)Significant difference in favour of the intervention0.111 (0.001–0.221)

Reasons for discontinuations

Medication no longer indicated
60%
Safety issues
20%
Efficacy issues
15%
Patient preferences
5%

Original publication

Physician‐led medication reviews in polypharmacy patients treated with at least 12 medications in a type 2 diabetes outpatient clinic: A randomised trial. Diabet Med. Published 31 January 2023. doi:10.1111/dme.15052

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.